Ratings by Independent Research GmbH
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 11/11/2021 | Tobias Gottschalt | Pfizer | PFE | Upgrade | Buy (Hold) |
54.00 (51.00) |
47.30 (24.72) |
-47.74% | Details |
| 8/4/2021 | Lars Lusebrink | Procter & Gamble | PG | Downgrade | Hold (Buy) |
154.00 (N/A) |
143.95 (150.86) |
4.8% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 13 more... | |||||||||


